Type to search

Medicago and GSK Announce the Approval by Health Canada of COVIFENZ®, an Adjuvanted Plant-based COVID-19 Vaccine | Pharmtech Focus
Medicago and GSK Announce Positive Interim Phase 2 Results for Adjuvanted Covid-19 Vaccine Candidate | Pharmtech Focus